We are live on ! Find out more
HALO icon

Halozyme

202 hedge funds and large institutions have $2.1B invested in Halozyme in 2019 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 80 increasing their positions, 62 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

456% more call options, than puts

Call options by funds: $18.1M | Put options by funds: $3.25M

30% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 20

29% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 62

8% more capital invested

Capital invested by funds: $1.95B → $2.1B (+$152M)

0.79% more ownership

Funds ownership: 83.47%84.26% (+0.79%)

0% more funds holding

Funds holding: 201202 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
202
Holders Change
+1
Holders Change %
+0.5%
% of All Funds
4.37%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
80
Reduced
62
Closed
20
Calls
$18.1M
Puts
$3.25M
Net Calls
+$14.8M
Net Calls Change
+$6.91M

HALO Hedge Fund Activity: Q2 2019 in Review

202 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q2 2019, worth a combined $2.1B — up 7.8% from $1.95B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new HALO positions and 20 closed out — a net gain of 6 holders — while 80 added to existing stakes and 62 trimmed.

The largest buyer was Bellevue Group, opening a new position worth an estimated $133M. The largest seller was Third Security, cutting an estimated $54.5M.

  • 202 institutional investors held Halozyme (HALO) as of Q2 2019, up from 201 in Q1 2019.
  • Funds reported $2.1B of Halozyme stock for Q2 2019, up 7.8% quarter-over-quarter.
  • 26 funds opened new Halozyme positions in Q2 2019 and 20 closed out, a net change of +6 holders.
  • The largest Halozyme buyer in Q2 2019 was Bellevue Group, an estimated $133M added.
  • The largest Halozyme seller in Q2 2019 was Third Security, an estimated $54.5M sold.

Based on aggregated 13F filings for Q2 2019.